Radioenzymatic assay of plasma adrenaline and noradrenaline: evidence for a catechol-O-methyltransferase (COMT) inhibiting factor associated with essential hypertension
- 1 November 1982
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 125 (3) , 319-327
- https://doi.org/10.1016/0009-8981(82)90263-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Novel Double-Isotope Technique for Enzymatic Assay of Catecholamines, Permitting High Precision, Sensitivity and Plasma Sample CapacityClinical Science, 1981
- Determination of free and conjugated catecholamines and l-3,4-dihydroxyphenylalanine in plasma and urine: evidence for a catechol-O-methyltransferase inhibitor in uraemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Single isotope derivative (radioenzymatic) methods in the measurement of catecholaminesMetabolism, 1980
- A radioenzymatic assay for femtomole determination of catecholamines using α-methyldopamine as an internal standardLife Sciences, 1980
- Stability of human plasma catecholaminesScandinavian Journal of Clinical and Laboratory Investigation, 1980
- A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acidLife Sciences, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole rangeLife Sciences, 1976
- A Sensitive and Specific Double-Isotope Derivative Method for the Determination of Catecholamines in Biological SpecimensThe Lancet Healthy Longevity, 1968